Mesoblast
MESO
$6.20
Share price
3.41%
Change (1 day)
84.67%
Change (1 year)
Categories
Mesoblast (MESO) - Cash on Hand
Cash on Hand as of June 2023 : $70.92 M
According to Mesoblast
's latest financial reports the company has $70.92 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Mesoblast - Cash on Hand chart (from 2012 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-06-30 | $70.92 M | 18.13% |
| 2022-06-30 | $60.03 M | -56% |
| 2021-06-30 | $0.13 B | 5.83% |
| 2020-06-30 | $0.12 B | 157.81% |
| 2019-06-30 | $50 M | 34.35% |
| 2018-06-30 | $37.22 M | 382.01% |
| 2017-06-30 | $7.72 M | -64.68% |
| 2016-06-30 | $21.86 M | 3.47% |
| 2015-06-30 | $21.12 M | 452.03% |
| 2014-06-30 | $3.82 M | -51.4% |
| 2013-06-30 | $7.87 M | 467.36% |
| 2012-06-30 | $1.38 M | -99.47% |
| 2011-06-30 | $0.26 B | 721.32% |
| 2010-06-30 | $32.04 M | 93.93% |
| 2009-06-30 | $16.52 M | 17.26% |
| 2008-06-30 | $14.09 M | 16.92% |
| 2007-06-30 | $12.05 M | 53.47% |
| 2006-06-30 | $7.85 M | -47.96% |
| 2005-06-30 | $15.09 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.13 M | -99.81% | Bahamas |
 NRC Health
NRC | $6.65 M | -90.62% | 🇺🇸 USA |